Beating the Odds with Combination Therapy (IMAGE)
Caption
Survival curves reveal the clinical impact: patients with the CLASS 3G mutation (red line) progress quickly on single-agent targeted therapy, but their outcomes improve dramatically when starting with a combination of targeted therapy and chemotherapy (green line).
Credit
©Science China Press
Usage Restrictions
Use with credit.
License
Original content